University Collegue of London (UCL)London, England, United Kingdom
Disclosure information not submitted.
Paper 32 - IMMUNOSARC II MASTER TRIAL (PHASE II OF SUNITINIB AND NIVOLUMAB): RESULTS FROM THE VASCULAR SARCOMAS COHORT. A GEIS, ISG AND UCL STUDY.
Friday, November 3, 20239:00 AM – 10:00 AM
Paper 66 - ARE TREATMENT DELAYS ASSOCIATED WITH A WORSE OUTCOME IN PATIENTS WITH HIGH-GRADE OSTEOSARCOMA? A RETROSPECTIVE ANALYSIS OF DATA FROM THE EURAMOS-1 TRIAL
Saturday, November 4, 202310:00 AM – 11:00 AM
